These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35490739)

  • 21. Genomic and epidemiologic surveillance of SARS-CoV-2 in Southern Brazil and identification of a new Omicron-L452R sublineage.
    da Silva MS; Gularte JS; Filippi M; Demoliner M; Girardi V; Mosena ACS; Pereira VMAG; Hansen AW; Weber MN; de Almeida PR; Fleck JD; Bó AGBLD; Jones MH; Friedrich F; Filho LA; Klamt F; Spilki FR
    Virus Res; 2022 Nov; 321():198907. PubMed ID: 36055471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using Traveler-based Genomic Surveillance at 4 US Airports, September 2021-January 2022.
    Wegrzyn RD; Appiah GD; Morfino R; Milford SR; Walker AT; Ernst ET; Darrow WW; Li SL; Robison K; MacCannell D; Dai D; Girinathan BP; Hicks AL; Cosca B; Woronoff G; Plocik AM; Simen BB; Moriarty L; Guagliardo SAJ; Cetron MS; Friedman CR
    Clin Infect Dis; 2023 Feb; 76(3):e540-e543. PubMed ID: 35686436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic Surveillance for Monitoring Variants of Concern: SARS-CoV-2 Delta, Omicron, and Beyond.
    Guest PC
    Methods Mol Biol; 2022; 2511():407-413. PubMed ID: 35838978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2.
    Zou J; Kurhade C; Xia H; Liu M; Xie X; Ren P; Shi PY
    Nat Commun; 2022 May; 13(1):2956. PubMed ID: 35618703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convolutional Neural Networks Based on Sequential Spike Predict the High Human Adaptation of SARS-CoV-2 Omicron Variants.
    Nan BG; Zhang S; Li YC; Kang XP; Chen YH; Li L; Jiang T; Li J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
    Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022.
    Lindh E; Smura T; Blomqvist S; Liitsola K; Vauhkonen H; Savolainen L; Ikonen J; Ronkainen J; Taskila J; Taskila T; Sakaranaho P; Savolainen-Kopra C; Vapalahti O; Ikonen N
    Euro Surveill; 2022 Apr; 27(16):. PubMed ID: 35451361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
    Andreano E; Paciello I; Marchese S; Donnici L; Pierleoni G; Piccini G; Manganaro N; Pantano E; Abbiento V; Pileri P; Benincasa L; Giglioli G; Leonardi M; Maes P; De Santi C; Sala C; Montomoli E; De Francesco R; Rappuoli R
    Nat Commun; 2022 Jun; 13(1):3375. PubMed ID: 35697673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notes from the Field: Early Identification of the SARS-CoV-2 Omicron BA.2.86 Variant by the Traveler-Based Genomic Surveillance Program - Dulles International Airport, August 2023.
    Bart SM; Rothstein AP; Philipson CW; Smith TC; Simen BB; Tamin A; Atherton LJ; Harcourt JL; Taylor Walker A; Payne DC; Ernst ET; Morfino RC; Ruskey I; Friedman CR
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(43):1168-1169. PubMed ID: 37883296
    [No Abstract]   [Full Text] [Related]  

  • 31. SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant.
    Sentis C; Billaud G; Bal A; Frobert E; Bouscambert M; Destras G; Josset L; Lina B; Morfin F; Gaymard A; The Covid-Diagnosis Hcl Study Group
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations.
    Almeida LT; Gonçalves AB; Franco-Luiz APM; Silva TBS; Alves PA; Monte-Neto RLD
    Mem Inst Oswaldo Cruz; 2022; 117():e220050. PubMed ID: 35766650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Repeat Pattern of Founder Events for SARS-CoV-2 Variants in Alaska.
    Haan TJ; Smith LK; DeRonde S; House E; Zidek J; Puhak D; Mullen L; Redlinger M; Parker J; Barnes BM; Burkhead JL; Knall C; Bortz E; Chen J; Drown DM
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5.
    Hewins B; Richardson C; Rubino S; Kelvin A; Toloue Ostadgavahi A; Kelvin DJ
    J Infect Dev Ctries; 2022 Jul; 16(7):1122-1125. PubMed ID: 35905015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M
    J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
    Ao Y; Li J; Wei Z; Wang Z; Tian H; Qiu Y; Fu X; Ma W; Li L; Zeng M; Xu J
    J Infect; 2022 Nov; 85(5):573-607. PubMed ID: 35934137
    [No Abstract]   [Full Text] [Related]  

  • 37. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant.
    Tanaka H; Ogata T; Shibata T; Nagai H; Takahashi Y; Kinoshita M; Matsubayashi K; Hattori S; Taniguchi C
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Ogata T; Tanaka H
    Emerg Infect Dis; 2024 Jan; 30(1):207. PubMed ID: 38146992
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain.
    Chin AWH; Lai AMY; Peiris M; Man Poon LL
    Emerg Infect Dis; 2022 Aug; 28(7):1515-1517. PubMed ID: 35550234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.